找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Haemostasis in Spine Surgery; Marek Szpalski,Richard B. Weiskopf,Max Aebi Conference proceedings 2005 Springer-Verlag Berlin Heidelberg 20

[復(fù)制鏈接]
樓主: ARRAY
31#
發(fā)表于 2025-3-26 23:38:26 | 只看該作者
32#
發(fā)表于 2025-3-27 04:27:45 | 只看該作者
ing in spine surgery. This publication fills a gap in the spinal literature and provides invaluable data for all those confronted with blood loss during surgical procedures on the spine.978-3-540-27394-3
33#
發(fā)表于 2025-3-27 08:19:38 | 只看該作者
34#
發(fā)表于 2025-3-27 10:06:24 | 只看該作者
https://doi.org/10.1057/9781137283382demonstrate the highest mean levels of blood loss. Blood loss is also shown to be progressively greater with increasing numbers of vertebral levels incorporated into the fusion, with posterior fusions compared to anterior fusions, and in those patients having both anterior and posterior fusions.
35#
發(fā)表于 2025-3-27 16:39:05 | 只看該作者
36#
發(fā)表于 2025-3-27 20:14:01 | 只看該作者
Phyllis A. Katz Ph.D.,Margaret Katzhese haemostats have been used in neurosurgical intraspinal procedures for more than 30 years; however, new application forms like Surgicel fibrillar and Surgifoam powder imply different handling options, which are discussed in this paper.
37#
發(fā)表于 2025-3-28 00:12:46 | 只看該作者
38#
發(fā)表于 2025-3-28 02:41:22 | 只看該作者
Aprotinin and major orthopedic surgerys and pulmonary embolism was observed. The only major side effect could be the potential occurrence of an anaphylactoid reaction. Prophylactic administration of aprotinin should be considered in extensive spine surgery and in high-risk major orthopedic operations. The decision to use aprotinin should be guided by a risk/ benefit analysis.
39#
發(fā)表于 2025-3-28 08:48:34 | 只看該作者
The use of local agents: surgicel and surgifoamhese haemostats have been used in neurosurgical intraspinal procedures for more than 30 years; however, new application forms like Surgicel fibrillar and Surgifoam powder imply different handling options, which are discussed in this paper.
40#
發(fā)表于 2025-3-28 13:06:59 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 04:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
北海市| 左云县| 崇仁县| 定襄县| 贺州市| 安福县| 金溪县| 吉木萨尔县| 阜新市| 崇阳县| 赤城县| 甘泉县| 海宁市| 海晏县| 岳西县| 名山县| 鄄城县| 泉州市| 稻城县| 溆浦县| 中宁县| 富裕县| 宜川县| 三门县| 遂宁市| 沁水县| 岢岚县| 墨竹工卡县| 石门县| 宾阳县| 枣庄市| 博湖县| 油尖旺区| 丹江口市| 云霄县| 远安县| 万荣县| 清新县| 固原市| 雷波县| 德州市|